Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Prevalence and Determinants of High-risk Human Papillomavirus Infection in Women with High Socioeconomic Status in Seoul, Republic of Korea

  • Kim, Ki-Dong (Department of Obstetrics and Gynecology, Seoul National University Bundang Hospital) ;
  • Kim, Jin-Ju (Department of Obstetrics and Gynecology, Seoul National University College of Medicine) ;
  • Kim, Sun-Mie (Department of Obstetrics and Gynecology, Seoul National University College of Medicine) ;
  • No, Jae-Hong (Department of Obstetrics and Gynecology, Seoul National University Bundang Hospital) ;
  • Kim, Yong-Beom (Department of Obstetrics and Gynecology, Seoul National University Bundang Hospital)
  • Published : 2012.01.31
Download PDF
⟨ Previous Next ⟩

Abstract

We aimed to estimate the prevalence of high-risk human papillomavirus (HPV) infections in women of high socioeconomic status (SES) in Seoul, Republic of Korea and to identify risk factors. This study included 13,386 women visiting a prestigious healthcare center located in Seoul between 2003 and 2008. High-risk HPV infections were detected in 994 (7%) and the age-standardized prevalence was 8%. Abnormal Pap smear results ${\geq}$ atypical squamous cells of unknown significance (ASCUS) were observed in 280 of 12,080 women (2%). Based on univariate analysis, age, level of education and number of children were associated with high-risk HPV infections. Based on multivariate analysis, age and high-risk HPV infections had an inverse relationship. In women with high SES in Seoul, the prevalence of high-risk HPV infection was 7% and the age-standardized prevalence was 8%. Age was a strong determinant of high-risk HPV infection.

Keywords

References

  1. Bae JH, Lee SJ, Kim CJ, et al (2008). Human papillomavirus (HPV) type distribution in Korean women: a metaanalysis. J Microbiol Biotechnology, 18, 788-794.
  2. Bao YP, Li N, Smith JS, et al(2008). Human papillomavirus type distribution in women from Asia: a meta-analysis. Int J Gynecological Cancer, 18, 71-79.
  3. Bosch FX, Manos MM, Munoz N, et al(1995). Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst, 87, 796-802. https://doi.org/10.1093/jnci/87.11.796
  4. Clifford GM, Gallus S, Herrero R, et al (2005). Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet, 366, 991-998. https://doi.org/10.1016/S0140-6736(05)67069-9
  5. Clifford GM, Rana RK, Franceschi S, et al(2005). Human papillomavirus genotype distribution in low-grade cervical lesions: comparison by geographic region and with cervical cancer. Cancer Epidemiol Biomarkers Prev, 14, 1157-1164. https://doi.org/10.1158/1055-9965.EPI-04-0812
  6. Clifford GM, Smith JS, Aguado T, et al(2003). Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis. Br J Cancer, 89, 101- 105. https://doi.org/10.1038/sj.bjc.6601024
  7. Clifford GM, Smith JS, Plummer M, et al(2003). Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer, 88, 63-73. https://doi.org/10.1038/sj.bjc.6600688
  8. de Villiers EM, Fauquet C, Broker TR, et al(2004). Classification of papillomaviruses. Virology, 324, 17-27. https://doi.org/10.1016/j.virol.2004.03.033
  9. Franceschi S, Herrero R, Clifford GM, et al(2006). Variations in the age-specific curves of human papillomavirus prevalence in women worldwide. Int J Gynecological Cancer, 119, 2677-2684. https://doi.org/10.1002/ijc.22241
  10. Jemal A, Bray F, Center MM, et al(2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90. https://doi.org/10.3322/caac.20107
  11. Joo WD, Kim SH, Kim DY, et al(2004). Prevalence of human papillomavirus infection in Korean women: risks of abnormal Pap smear and cervical neoplasia. J Gynecol Oncol, 15, 309-316.
  12. Kahn JA, Lan D, Kahn RS(2007). Sociodemographic factors associated with high-risk human papillomavirus infection. Obstetrics Gynecol, 110, 87-95. https://doi.org/10.1097/01.AOG.0000266984.23445.9c
  13. Kim YT (2009). Current status of cervical cancer and HPV infection in Korea. J Gynecol Oncol, 20, 1-7. https://doi.org/10.3802/jgo.2009.20.1.1
  14. Korea Statistical Information Service (http://www.kosis.kr/abroad/abroad_01List.jsp?parentId=A) Accessed at 12 April, 2011.
  15. Nam K, Chung S, Kim J, et al(2009). Factors associated with HPV persistence after conization in patients with negative margins. J Gynecol Oncol, 20, 91-5. https://doi.org/10.3802/jgo.2009.20.2.91
  16. Oh JK, Franceschi S, Kim BK, et al(2009). Prevalence of human papillomavirus and Chlamydia trachomatis infection among women attending cervical cancer screening in the Republic of Korea. Eur J Cancer Prev, 18, 56-61. https://doi.org/10.1097/CEJ.0b013e328305a0a6
  17. Shin HR, Franceschi S, Vaccarella S, et al(2004). Prevalence and determinants of genital infection with papillomavirus, in female and male university students in Busan, South Korea. J Infectious Dis, 190, 468-76. https://doi.org/10.1086/421279
  18. Shin HR, Lee DH, Herrero R, et al(2003). Prevalence of human papillomavirus infection in women in Busan, South Korea. Int J Cancer, 103, 413-21. https://doi.org/10.1002/ijc.10825
  19. Silva KC, Rosa ML, Moyse N, et al(2009). Risk factors associated with human papillomavirus infection in two populations from Rio de Janeiro, Brazil. Memorias do Instituto Oswaldo Cruz, 104, 885-891 https://doi.org/10.1590/S0074-02762009000600011

Cited by

  1. Scoring System and Management Algorithm Assessing the Role of Survivin Expression in Predicting Progressivity of HPV Infections in Precancerous Cervical Lesions vol.14, pp.3, 2013, https://doi.org/10.7314/APJCP.2013.14.3.1643
  2. Prevalence and Genotype Distribution of HPV among Women Attending a Cervical Cancer Screening Mobile Unit in Lampang, Thailand vol.15, pp.15, 2014, https://doi.org/10.7314/APJCP.2014.15.15.6151
  3. Development of In-House Multiplex Real Time PCR for Human Papillomavirus Genotyping in Iranian Women with Cervical Cancer and Cervical Intraepithelial Neoplasia vol.15, pp.15, 2014, https://doi.org/10.7314/APJCP.2014.15.15.6257
  4. Cervical Pathology in Cytology-Negative/HPV-Positive Women: Results from Lampang Cancer Hospital, Thailand vol.15, pp.18, 2014, https://doi.org/10.7314/APJCP.2014.15.18.7951
  5. Use of Fast Transfer Analysis Cartridges for Cervical Sampling and Real Time PCR Based High Risk HPV Testing in Cervical Cancer Prevention - a Feasibility Study from South India vol.16, pp.14, 2015, https://doi.org/10.7314/APJCP.2015.16.14.5993
  6. Impact of age on the false negative rate of human papillomavirus DNA test in patients with atypical squamous cells of undetermined significance vol.58, pp.2, 2015, https://doi.org/10.5468/ogs.2015.58.2.117